The White House announced on Tuesday an agreement between Johnson & Johnson with the Merck laboratory to help it manufacture its vaccine against covid-19 and thus increase production volume.
The agreement is part of President Joe Biden's goal of having enough vaccines for 300 million Americans by the end of next May.